Earlier this month, Cronos Group, a vertically integrated Canadian marijuana company, entered into a partnership with Boston-based biotech startup Ginkgo Bioworks to develop cannabinoids using organism design and development technology.
Why Cronos Group's Partnership To Produce Cultured Cannabinoids Could Be A Big Deal
Forbes - 19 Sep 2018 17:14
Earlier this month, Cronos Group, a vertically integrated Canadian marijuana company, entered into a partnership with Boston-based biotech startup Ginkgo Bioworks to develop cannabinoids using organism design and development technology.
Share this Article
Recommended